Your browser doesn't support javascript.
loading
Sex-Related Differences in Long-Term Outcomes After Early-Onset Myocardial Infarction.
Ardissino, Maddalena; Nelson, Adam J; Maglietta, Giuseppe; Malagoli Tagliazucchi, Guidantonio; Disisto, Caterina; Celli, Patrizia; Ferrario, Maurizio; Canosi, Umberto; Cernetti, Carlo; Negri, Francesco; Merlini, Piera Angelica; Tubaro, Marco; Berzuini, Carlo; Manzalini, Chiara; Ignone, Gianfranco; Campana, Carlo; Moschini, Luigi; Ponte, Elisabetta; Pozzi, Roberto; Fetiveau, Raffaela; Buratti, Silvia; Paraboschi, Elvezia Maria; Asselta, Rosanna; Botti, Andrea; Tuttolomondo, Domenico; Barocelli, Federico; Bricoli, Serena; Biagi, Andrea; Bonura, Rosario; Moccetti, Tiziano; Crocamo, Antonio; Benatti, Giorgio; Paoli, Giorgia; Solinas, Emilia; Notarangelo, Maria Francesca; Moscarella, Elisabetta; Calabrò, Paolo; Duga, Stefano; Magnani, Giulia; Ardissino, Diego.
Afiliación
  • Ardissino M; Imperial College London, London, United Kingdom.
  • Nelson AJ; Duke Clinical Research Institute, Durham, NC, United States.
  • Maglietta G; South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
  • Malagoli Tagliazucchi G; Clinical and Epidemiological Research Unit, University Hospital of Parma, Parma, Italy.
  • Disisto C; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Celli P; Department of Genetics, Evolution and Environment, UCL Genetics Institute, University College, London, United Kingdom.
  • Ferrario M; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Canosi U; Division of Cardiology, Ospedale San Camillo, Rome, Italy.
  • Cernetti C; Division of Cardiology, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy.
  • Negri F; Division of Cardiology, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy.
  • Merlini PA; Associazione per lo Studio della Trombosi in Cardiologia, Pavia, Italy.
  • Tubaro M; Cardiothoracic Department, University Hospital "Santa Maria della Miserciordia", Udine, Italy.
  • Berzuini C; Cardiothoracic Department, University Hospital "Santa Maria della Miserciordia", Udine, Italy.
  • Manzalini C; Associazione per lo Studio della Trombosi in Cardiologia, Pavia, Italy.
  • Ignone G; Division of Cardiology, Azienda Ospedaliera, Ospedale Niguarda Cà Granda, Milan, Italy.
  • Campana C; ICCU, Intensive and Interventional Cardiology, San Filippo Neri Hospital, Rome, Italy.
  • Moschini L; Centre for Biostatistics, School of Health Sciences, University of Manchester, Manchester, United Kingdom.
  • Ponte E; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Pozzi R; Department of Cardiology, Antonio Perrino Hospital, Azienda Sanitaria Locale di Brindisi, Brindisi, Italy.
  • Fetiveau R; Department of Cardiology, Sant'Anna Hospital, Como, Italy.
  • Buratti S; Division of Cardiology, Istituti Ospitalieri, Cremona, Italy.
  • Paraboschi EM; Hospital Universitario de Toledo, Servizio di Radiologia, Toledo, Spain.
  • Asselta R; Division of Cardiology, San Luigi Gonzaga University Hospital, Turin, Italy.
  • Botti A; Division of Cardiology, Ospedale di Legnano, Legnano, Italy.
  • Tuttolomondo D; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Barocelli F; Department of Biomedical Sciences, Humanitas Clinical and Research Center IRCCS, Humanitas University, Milan, Italy.
  • Bricoli S; Department of Biomedical Sciences, Humanitas Clinical and Research Center IRCCS, Humanitas University, Milan, Italy.
  • Biagi A; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Bonura R; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Moccetti T; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Crocamo A; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Benatti G; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Paoli G; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Solinas E; Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland.
  • Notarangelo MF; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Moscarella E; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Calabrò P; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Duga S; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Magnani G; Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Ardissino D; University Division of Clinical Cardiology, AORN Sant'Anna e San Sebastiano, Caserta, Department of Translational Medical Sciences, Luigi Vanvitelli University of Campania, Naples, Italy.
Front Cardiovasc Med ; 9: 863811, 2022.
Article en En | MEDLINE | ID: mdl-35859592
Importance: There is growing awareness of sex-related differences in cardiovascular risk profiles, but less is known about whether these extend to pre-menopausal females experiencing an early-onset myocardial infarction (MI), who may benefit from the protective effects of estrogen exposure. Methods: A nationwide study involving 125 Italian Coronary Care Units recruited 2,000 patients between 1998 and 2002 hospitalized for a type I myocardial infarction before the age of 45 years (male, n = 1,778 (88.9%). Patients were followed up for a median of 19.9 years (IQR 18.1-22.6). The primary composite endpoint was the occurrence of cardiovascular death, non-fatal myocardial re-infarction or non-fatal stroke, and the secondary endpoint of hospitalization for revascularisation by means of a percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG). Results: ST-elevation MI was the most frequent presentation among both men and women (85.1 vs. 87.4%, p = ns), but the men had a greater baseline coronary atherosclerotic burden (median Duke Coronary Artery Disease Index: 48 vs. 23; median Syntax score 9 vs. 7; both p < 0.001). The primary composite endpoint occurred less frequently among women (25.7% vs. 37.0%; adjusted hazard ratio: 0.69, 95% CI 0.52-0.91; p = 0.01) despite being less likely to receive treatment with most secondary prevention medications during follow up. Conclusions: There are significant sex-related differences in baseline risk factors and outcomes among patients with early-onset MI: women present with a lower atherosclerotic disease burden and, although they are less frequently prescribed secondary prevention measures, experience better long-term outcomes. Trial Registration: 4272/98 Ospedale Niguarda, Ca' Granda 03/09/1998.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido